PT-141

Product Overview:
· PT-141 (Bremelanotide) is a synthetic melanocortin receptor agonist studied in in vitro and preclinical research environments for its interaction with melanocortin signaling pathways and peptide-mediated neuroendocrine regulatory mechanisms.
· In laboratory settings, researchers investigate PT-141 for its role in melanocortin receptor activity, central nervous system signaling pathways, neurochemical communication systems, and peptide-mediated hormonal response mechanisms.
· Due to its receptor-binding characteristics and signaling profile, PT-141 is frequently utilized in studies involving melanocortin pathway modulation, neuroendocrine communication dynamics, and peptide-mediated cellular signaling interactions.
· Driven Ones LLC supplies PT-141 in a high-purity, research-grade lyophilized format, manufactured to support consistency, stability, and reproducibility across controlled laboratory research applications.

Intended Use:
· PT-141 is not approved for human or animal use.
· This product is intended strictly for in vitro laboratory research purposes only.
· Not intended for use in food, drugs, cosmetics, or diagnostic procedures.

Legal Disclaimer:
· This product has not been evaluated by the FDA.
· It is not intended to diagnose, treat, cure, or prevent any disease.
· For certified laboratories and qualified research professionals only.

Terms of Sale:
· All Driven Ones LLC sales are final.
· Purchasers affirm they are trained professionals and are responsible for proper handling, usage, and regulatory compliance.
· By purchasing, the buyer agrees to use this product strictly for lawful research purposes.